Cargando…
小细胞肺癌合并腺癌MDT治疗报道及文献综述
Small cell lung cancer (SCLC) is the most malignant lung cancer with the highest mortality. At present, the first-line standard treatment is still based on Etoposide and Platinum chemotherapy. However, for SCLC that progresses after first-line therapy, the treatment options are still very limited. S...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607282/ https://www.ncbi.nlm.nih.gov/pubmed/34802214 http://dx.doi.org/10.3779/j.issn.1009-3419.2021.102.37 |
Ejemplares similares
-
肺腺癌靶向治疗后小细胞肺癌转化的病例报道
Publicado: (2015) -
复合性小细胞肺癌伴EGFR基因突变1例报道及治疗体会
Publicado: (2014) -
小细胞肺癌卵巢转移2例及文献回顾
Publicado: (2010) -
经3种ALK抑制剂及化疗治疗的1例非小细胞肺癌病例报道
Publicado: (2021) -
阿来替尼治疗ALK阳性非小细胞肺癌:1例报告及文献复习
Publicado: (2021)